Resilient Leadership Through Cancer™

The Executive Continuity During Cancer Study™

A Confidential Research Initiative for Business Leaders

This confidential study explores how founders, CEOs, and senior executives navigate a cancer diagnosis while protecting leadership continuity, organizational stability, and long-term enterprise value.

This may be the first executive-level benchmark on leadership continuity during cancer.

Your perspective does more than share experience — it helps define standards, shape governance conversations, and influence how boards and leadership teams approach executive health risk. Even if you don’t have any direct experience in dealing with cancer, your input is still valuable.

This is not a medical survey. It is a strategic leadership study.

Findings may inform:

  • An Executive Findings Report
  • Board-level continuity discussions
  • Structured executive continuity frameworks
  • Private executive briefings
  • Industry thought leadership

By participating, you are contributing to structural change — helping shift cancer from a private leadership burden to a governance and business continuity conversation.

Responses are anonymous. You may optionally provide contact information to receive the Executive Findings Briefing — a confidential executive-level discussion focused on leadership exposure benchmarks, continuity risk, and emerging structural insights.

All personal information you provide will be kept completely confidential and not shared with anyone.

Please note that items with marked with a * are required.

SECTION I: EXPERIENCE & CONTEXT

Have you personally faced a cancer diagnosis while leading a business or organization?
What best describes your role?
Organization Size

SECTION II: BUSINESS CONTINUITY RISK

If diagnosed with cancer while leading, what business risks would concern you most?
Does your organization currently have a formal contingency plan for executive incapacity?

SECTION III: DISCLOSURE & DECISION PRESSURE

Please indicate your level of agreement with the following statement: “Leaders are expected to remain strong and steady, even during serious health challenges.”
Would you feel comfortable disclosing your cancer diagnosis to your leadership team, staff, or customers/clients?

SECTION IV: ISOLATION & SUPPORT

How likely is it that a leader would attempt to "handle it alone" during a cancer journey?
If you needed strategic guidance to protect your business during treatment, where would you turn first? Select up to 3.

SECTION V: STRATEGIC SUPPORT & VALUE

What area would feel MOST CRITICAL to address during treatment?
If a confidential executive-level resource existed specifically to help protect your company’s stability during treatment, how valuable would it be?
What would make such support credible to you?

SECTION VI: OPEN INSIGHT

OPTIONAL DEMOGRAPHICS

Age range:
Gender:

OPTIONAL FOLLOW-UP

If you would like to receive the results from this Executive Continuity During Cancer Study or future research updates:

Name

©2026 yourcancercoach.live | All Rights Reserved | Disclaimer